HP007 Monotherapy for Relapsed or Refractory Advanced Solid Tumors
HP007 Monotherapy for Relapsed or Refractory Advanced Solid Tumors
Recruiting · NCT07800936 · Registry updated 2026-09-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HP007 Monotherapy for Relapsed or Refractory Advanced Solid Tumors | Solid Tumors | Recruiting | Phase 1 | 2026-09-23 | NCT07800936 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Parr Biotechnology (Hebei) Co., Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Hospital of Jilin University | Changchun | China | 46 |